Executive Director, Global Procurement Third Party Risk Management at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Executive presence; able to command respect with scientific leaders, regulatory authorities, and C-suite executives
Impeccable ethics, especially critical in a regulated industry
Building trust with R&D, regulatory, commercial, Manufacturing, finance and operations leaders
Servicing as the bridge between executive leadership and on-the-ground teams
Championing digitalization, AI and process re-engineering to create future ready capabilities

Responsibilities

Setting and communicating a clear global vision aligned to enterprise priorities
Develop and execute a comprehensive TPRM strategy aligned with BMS’s policies, systems, and regulatory requirements
Lead the TPRM program framework, ensuring compliance and effective risk management
Lead the strategy and execution of the expanded TPRM program to incorporate assessment of all suppliers for potential risk within a single platform
Plan and lead Steering Committee meetings to ensure alignment across business units and share progress updates
Represent the TPRM program in key forums, including the Audit and Risk Management Subcommittee (ARMSC), Business Continuity PMO, and IT Third Party Assessment Steering Committee
Serve as the primary point of contact for audits conducted by GIA, supporting audit requests and presenting TPRM updates
Lead the Functional TPRM Operations team and ensure robust risk management practices across all business units
In partnership with Corporate Ethics & Compliance, drive continuous improvement, manage escalations, and support both regulatory and organizational priorities including non-GxP goods and services suppliers
Identify and drive changes to TPRM processes, policies, and tools, integrating feedback from stakeholder groups such as FTPRM, Risk SMEs, Global Procurement, leadership, and business unit leaders
Ensure policies are up-to-date
Oversee the TPRM framework, ensuring alignment with BMS’s policies, systems, and regulatory requirements
Define, execute, and advance BMS’ global TPRM strategy, processes, and technology as it applies when procuring and participating in the procurement of GxP goods and services on behalf of BMS
Lead continuous improvement and change management initiatives

Skills

TPRM

Procurement

GxP Compliance

Risk Management

Regulatory Compliance

Supplier Risk Assessment

Global Strategy

Stakeholder Influence

Team Leadership

Supply Chain Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free